RARα antagonist 1 (compound 21) is an orally active and selective retinoic acid receptor α(RARα) antagonist, with the IC50 of 4.6nM[1].
References:
[1]. Al Noman MA, et al. Strategies for developing retinoic acid receptor alpha-selective antagonists as novel agents for male contraception [published online ahead of print, 2023 Sep 25]. Eur J Med Chem. 2023;261:115821.
















